Dendritic cell-based vaccine research against cancer

Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect

CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses

Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment

Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer

Emerging treatment strategies for glioblastoma multiforme

Perspectives for immunotherapy in glioblastoma treatment

Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression

Dendritic cell cancer vaccines: from the bench to the bedside

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma